Profiling of small nucleolar RNAs by next generation sequencing: Potential new players for breast cancer prognosis

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Krishnan, Preethi ^a   Ghosh, Sunita ^a,b   Wang, Bo ^c   Heyns, Mieke ^c   Graham, Kathryn ^a,b   Mackey, John R ^a,b   Kovalchuk, Olga ^c   Damaraju, Sambasivarao ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL NUCLEOLAR RNA; SMALL NUCLEOLAR RNA 46; SMALL NUCLEOLAR RNA 89; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE TARGETING; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEXT GENERATION SEQUENCING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA ANALYSIS; BREAST TUMOR; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

BREAST NEOPLASMS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RNA, SMALL NUCLEOLAR;

EID: 84992391420     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162622     Document Type: Article

References (52)

1. Bogdanova N, Helbig S, Dörk T. Hereditary breast cancer: Ever more pieces to the polygenic puzzle. 2013; 11: 12. doi:10.1186/1897-4287-11-12 PMID: 24025454.
2. Hutchinson L. Breast cancer: challenges, controversies, breakthroughs. Nat Rev Clin Oncol. 2010; 7: 669-670. doi:10.1038/nrclinonc.2010.192 PMID: 21116236.
3. Aparicio S, Mardis E. Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope. Genome Biol. 2014; 15: 463-463. PMID: 25315013.
4. Ribelles N, Perez-Villa L, Jerez JM, Pajares B, Vicioso L, Jimenez B, et al. Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index. Breast Cancer Res. 2013; 15: R98-R98. PMID: 24148581.
5. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-Treated, node-negative breast cancer. N Engl J Med. 2004; 351: 2817-2826. PMID: 15591335.
6. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75: 843-854. PMID: 8252621.
7. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993; 75: 855-862. PMID: 8252622.
8. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 2004; 64: 3087-3095. PMID: 15126345.
9. Papagiannakopoulos T, Shapiro A, Kosik KS. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008; 68: 8164-8172. doi:10.1158/0008-5472.CAN-08-1305 PMID: 18829576.
10. Venkataraman S, Birks DK, Balakrishnan I, Alimova I, Harris PS, Patel PR, et al. MicroRNA 218 acts as a tumor suppressor by targetingmultiple cancer phenotype-Associated genes in medulloblastoma. J Biol Chem. 2013; 288: 1918-1928. doi:10.1074/jbc.M112.396762 PMID: 23212916.
11. Bertoli G, Cava C, Castiglioni I. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics. 2015; 5: 1122-1143. doi:10.7150/thno.11543 PMID: 26199650.
12. Chan M, Liaw CS, Ji SM, Tan HH, Wong CY, Thike AA, et al. Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res. 2013; 19: 4477-4487. doi:10.1158/1078-0432.CCR-12-3401 PMID: 23797906.
13. Krishnan P, Ghosh S, Wang B, Li D, Narasimhan A, Berendt R, et al. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer. BMC Genomics. 2015; 16: 735. doi:10.1186/s12864-015-1899-0PMID: 26416693.
14. Li X, Zhang Y, Zhang Y, Ding J, Wu K, Fan D. Survival prediction of gastric cancer by a seven-micro- RNA signature. Gut. 2010; 59: 579-585doi:10.1136/gut.2008.175497 PMID: 19951901.
15. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: A diagnostic marker for lung cancer. Clin Lung Cancer. 2009; 10: 42-46. doi:10.3816/CLC.2009.n.006 PMID: 19289371.
16. Yu S, Chen H, Chang G, Chen C, Chen H, Singh S, et al. Article:MicroRNA Signature Predicts Survival and Relapse in Lung Cancer. Cancer Cell. 2008; 13: 48-57. doi:10.1016/j.ccr.2007.12.008 PMID: 18167339.
17. Martens-Uzunova E, Olvedy M, Jenster G. Beyond microRNA-Novel RNAs derived from small noncoding RNA and their implication in cancer. Cancer Lett. 2013; 340: 201-211. doi:10.1016/j.canlet.2012.11.058 PMID: 23376637.
18. Dieci G, Preti M, Montanini B. Eukaryotic snoRNAs: A paradigm for gene expression flexibility. Genomics. 2009; 94: 83-88. doi:10.1016/j.ygeno.2009.05.002 PMID: 19446021.
19. Weinstein LB, Steitz JA. Guided tours: from precursor snoRNA to functional snoRNP. Curr Opin Cell Biol. 1999; 11: 378-384. PMID: 10395551.
20. Filipowicz W, Pogacic V. Review: Biogenesis of small nucleolar ribonucleoproteins. Curr Opin Cell Biol. 2002; 14: 319-327. PMID: 12067654.
21. Sahoo T, del Gaudio D, German JR, Shinawi M, Peters SU, Person RE, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008; 40: 719-721. doi:10.1038/ng.158 PMID: 18500341.
22. Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, Listenberger LL, et al. Article: Small Nucleolar RNAs U32a, U33, and U35a Are Critical Mediators of Metabolic Stress. Cell Metab. 2011; 14: 33- 44. doi:10.1016/j.cmet.2011.04.009 PMID: 21723502.
23. Ronchetti D, Mosca L, Cutrona G, Tuana G, Gentile M, Fabris S, et al. Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia. BMC Med Genomics. 2013; 6: 27. doi:10.1186/1755-8794-6-27 PMID: 24004562.
24. Xu G, Yang F, Ding C, Zhao L, Ren H, Zhao P, et al. Small nucleolar RNA 113-1 suppresses tumorigenesis in hepatocellular carcinoma. Mol Cancer. 2014; 13: 216-216. doi:10.1186/1476-4598-13-216 PMID: 25217841.
25. Okugawa Y, Toiyama Y, Toden S, Mitoma H, Nagasaka T, Tanaka K, et al. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Gut. 2015.
26. Ravo M, Cordella A, Rinaldi A, Bruno G, Alexandrova E, Saggese P, et al. Small non-coding RNA deregulation in endometrial carcinogenesis. Oncotarget. 2015; 6: 4677-4691. PMID: 25686835.
27. Liao J, Yu L, Mei Y, Guarnera M, Shen J, Li R, et al. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer. 2010; 9: 198-198. doi:10.1186/1476-4598-9-198 PMID: 20663213.
28. Gao L, Ma J, Mannoor K, Guarnera MA, Shetty A, Zhan M, et al. Genome-wide small nucleolar RNA expression analysis of lung cancer by next-generation deep sequencing. Int J Cancer. 2015; 136: E623-E629. doi:10.1002/ijc.29169 PMID: 25159866.
29. Dong X, Guo P, Boyd J, Sun X, Li Q, Zhou W, et al. Implication of snoRNA U50 in human breast cancer. J Genet Genomics. 2009; 36: 447-454. doi:10.1016/S1673-8527(08)60134-4PMID: 19683667.
30. Su H, Xu T, Ganapathy S, Shadfan M, Long M, Huang TH, et al. Elevated snoRNA biogenesis is essential in breast cancer. Oncogene. 2014; 33: 1348-1358. doi:10.1038/onc.2013.89PMID: 23542174.
31. Ender C, Krek A, Friedländer MR, Beitzinger M, Weinmann L, Chen W, et al. A Human snoRNA with MicroRNA-Like Functions. Mol Cell. 2008; 32: 519-528. doi:10.1016/j.molcel.2008.10.017PMID: 19026782.
32. Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J. Human box C/D snoRNAs with miRNA like functions: Expanding the range of regulatory RNAs. Nucleic Acids Res. 2011; 39: 675-686. doi:10.1093/nar/gkq776 PMID: 20846955.
33. Dobbin KK, Simon RM. Sample size planning for developing classifiers using high-dimensionalDNA microarray data. Biostatistics. 2007; 8: 101-117. PMID: 16613833.
34. Dobbin KK, Zhao Y, Simon RM. How large a training set is needed to develop a classifier for microarray data? Clin Cancer Res. 2008; 14: 108-114. doi:10.1158/1078-0432.CCR-07-0443PMID: 18172259.
35. Weng L, Wu X, Gao H, Mu B, Li X, Wang J, et al. MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol. 2010; 222: 41-51. doi:10.1002/path.2736 PMID: 20593407.
36. Krishnan P, Ghosh S, Graham K, Mackey JR, Kovalchuk O, Damaraju S. Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer. Oncotarget. 2016: May.
37. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of shortDNA sequences to the human genome. Genome Biol. 2009; 10: R25-R25. doi:10.1186/gb-2009-10-3-r25 PMID: 19261174.
38. Kersey PJ, Allen JE, Armean I, Boddu S, Bolt BJ, Carvalho-Silva D, et al. Ensembl Genomes 2016: more genomes, more complexity. Nucleic Acids Res. 2016; 44: D574-D580. doi:10.1093/nar/gkv1209 PMID: 26578574.
39. Gasparini P, Cascione L, Fassan M, Lovat F, Guler G, Balci S, et al. microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget. 2014; 5: 1174-1184. PMID: 24632568.
40. Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin GA, Borresen-Dale A, et al. A SerumMicro- RNA Signature Predicts Tumor Relapse and Survival in Triple Negative Breast Cancer Patients. Clin Cancer Res. 2015; 21: 1207-1214. doi:10.1158/1078-0432.CCR-14-2011 PMID: 25547678.
41. Liu N, Cui RX, Sun Y, Guo R, Mao YP, Tang LL, et al. A four-miRNA signature identified from genomewide serummiRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int J Cancer. 2014; 134: 1359-1368. doi:10.1002/ijc.28468PMID: 23999999.
42. Su Y, Ni Z, Wang G, Cui J, Wei C, Wang J, et al. Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p. Int Immunopharmacol. 2012; 13: 468-475. doi:10.1016/j.intimp.2012.05.016 PMID: 22683180.
43. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008; 5: 621-628. doi:10.1038/nmeth.1226 PMID: 18516045.
44. Livak KJ, SchmittgenTD. Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-408. PMID: 11846609.
45. Germain DR, Graham K, Glubrecht DD, Hugh JC, Mackey JR, Godbout R. DEAD box 1: A novel and independent prognostic marker for early recurrence in breast cancer. Breast Cancer Res Treat. 2011; 127: 53-63. doi:10.1007/s10549-010-0943-7 PMID: 20499159.
46. Sai Lakshmi S, Agrawal S. piRNABank: A web resource on classified and clustered Piwi-interacting RNAs. Nucleic Acids Res. 2008; 36: D173-D177. PMID: 17881367.
47. Hashim A, Rizzo F, Marchese G, Ravo M, Tarallo R, Nassa G, et al. RNA sequencing identifies specific PIWI-interacting small non-coding RNA expression patterns in breast cancer. Oncotarget. 2014; 5: 9901-9910. PMID: 25313140.
48. Hall JS, Taylor J, Valentine HR, Irlam JJ, Eustace A, Hoskin PJ, et al. Enhanced stability of microRNA expression facilitates classification of FFPE tumour samples exhibiting near total mRNA degradation. Br J Cancer. 2012; 107: 684-694. doi:10.1038/bjc.2012.294PMID: 22805332.
49. Zhong F, Zhou N, Wu K, Guo Y, Tan W, Zhang H, et al. A SnoRNA-derived piRNA interacts with human interleukin-4 pre-mRNA and induces its decay in nuclear exosomes. Nucleic Acids Res. 2015; 43: 10474-10491. doi:10.1093/nar/gkv954 PMID: 26405199.
50. Chu L, Su MY, Maggi LB, Lu L, Mullins C, Crosby S, et al. Multiplemyeloma-Associated chromosomal translocation activates orphansnoRNA ACA11 to suppress oxidative stress. J Clin Invest. 2012; 122: 2793-2806doi:10.1172/JCI63051 PMID: 22751105.
51. Mei Y, Liao J, Shen J, Yu L, Liu B, Liu L, et al. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene. 2012; 31: 2794-2804. doi:10.1038/onc.2011.449PMID: 21986946.
52. Martens-Uzunova E, Hoogstrate Y, Kalsbeek A, Pigmans B, Vredenbregt-van dB, Dits N, et al. C/Dbox snoRNA-derived RNA production is associated with malignant transformation and metastatic progression in prostate cancer. Oncotarget. 2015; 6: 17430-17444. PMID: 26041889.